Christoph Brackmann

Insider Reports History

Location
Baar
Signature
Steven Robbins, as attorney in fact for Brackmann, Christoph
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christoph Brackmann:

Form 4 holding Chief Financial Officer

NovoCure Ltd

Security class
Stock Options (Right to buy)
Shares / value
81,499
Estimated value
$1,482,467
Report date
04 Mar 2025
Price
$18.19
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Financial Officer

NovoCure Ltd

Security class
Stock Option (Right to Buy)
Shares / value
80,674
Estimated value
Report date
03 Mar 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Christoph Brackmann

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .